{
"ProductData": {
"ID": "3.7.9.8.10.1",
"ProductType": "Others",
"BrandName": "HAMA Serum, Type I",
"ProductNameAddition": "lyophilizate",
"RegulatoryDisclaimer1": "For further processing only.",
"DisclaimerGroup1": "",
"RegulatoryDisclaimer2": null,
"DisclaimerGroup2": null,
"RegulatoryDisclaimer3": null,
"SampleType": [
],
"LicenseDisclaimers": [
],
"RelatedLinks": "",
"Clone": "",
"ControlTissue": [
""
],
"ISOtypes": "",
"Species": [
""
],
"StainLocalization": [
""
],
"ProductNameGlobal": "HAMA Serum Type I"
},
"ProductImageDetails": {
"ImagePath": "https://pim-media.roche.com/Images/CB_IMAGE_.png",
"ImageType": "Image main"
},
"Product2Taxonomy": {
"Product2TaxonomyReferences": [
{
"StructureSystemIdentifier": "Product_Grouping",
"StructureSystemName": "Product Grouping",
"NodeID": "02-0030",
"StructureNodeStatus": "valid",
"NodeName": "Interference Blocker"
},
{
"StructureSystemIdentifier": "OWP_Product_Types",
"StructureSystemName": "Product Types",
"NodeID": "70-005-00",
"StructureNodeStatus": "valid",
"NodeName": "Antibody interference blocker"
},
{
"StructureSystemIdentifier": "Product_Grouping",
"StructureSystemName": "Product Grouping",
"NodeID": "02-0035",
"StructureNodeStatus": "valid",
"NodeName": "Immunology Raw Materials"
},
{
"StructureSystemIdentifier": "OWP_Organization",
"StructureSystemName": "Organization",
"NodeID": "01-01-01-07-00",
"StructureNodeStatus": "valid",
"NodeName": "CustomBiotech and LifeScience"
},
{
"StructureSystemIdentifier": "OWP_Product_Types",
"StructureSystemName": "Product Types",
"NodeID": "70-006-00",
"StructureNodeStatus": "valid",
"NodeName": "Antibody interference controls"
},
{
"StructureSystemIdentifier": "Product_Solutions",
"StructureSystemName": "Product Solutions",
"NodeID": "520",
"StructureNodeStatus": "valid",
"NodeName": "CustomBiotech"
},
{
"StructureSystemIdentifier": "Lab_Type",
"StructureSystemName": "Lab Types",
"NodeID": "180-00",
"StructureNodeStatus": "invalid",
"NodeName": ""
},
{
"StructureSystemIdentifier": "Applications",
"StructureSystemName": "Applications",
"NodeID": "99-00-00",
"StructureNodeStatus": "invalid",
"NodeName": ""
},
{
"StructureSystemIdentifier": "OWP_Techniques",
"StructureSystemName": "Techniques",
"NodeID": "999-00",
"StructureNodeStatus": "invalid",
"NodeName": ""
},
{
"StructureSystemIdentifier": "Disease_Areas",
"StructureSystemName": "Disease Areas",
"NodeID": "99-00-00",
"StructureNodeStatus": "invalid",
"NodeName": ""
},
{
"StructureSystemIdentifier": "Pathogens",
"StructureSystemName": "Pathogens",
"NodeID": "99-00-00",
"StructureNodeStatus": "invalid",
"NodeName": ""
},
{
"StructureSystemIdentifier": "OWP_Family",
"StructureSystemName": "Product Families",
"NodeID": "999",
"StructureNodeStatus": "invalid",
"NodeName": ""
},
{
"StructureSystemIdentifier": "Health_Topics",
"StructureSystemName": "Health Topics",
"NodeID": "99-00-00",
"StructureNodeStatus": "invalid",
"NodeName": ""
}
]
},
"Product2Materials": {
"P2MaterialReferences": [
{
"MaterialNum": "11767275103",
"MaterialDescription": "Hama-Serum1-Qual.Standard *SQ",
"RegisteredProductName": "HAMA Serum, Type I",
"GTIN": "",
"ProductCategoryText": "Reagents, kits",
"OldMaterialNumber": "",
"PackSizePIM360": "1 vial",
"PackSizeDescPIM360": "reconstitution in 1 mL",
"MaterialAnnotation": "CustomBiotech product. Please contact your
local representative.",
"ReadyForUse": "",
"OrderInformation": "Will be supplied as \"Hama-Serum I - Qual. Standard *SQ\". Unit of measure is \"piece\"."
}
]
},
"Product2Products": {
"Product2ProductReference": [
]
},
"ProductSpec": [
{
"ProductSpecVariant": {
"Chapters": [
{
"Name": "Applications",
"Value": "HAMA Serum Type I is primarily intended for polyvalent and spontaneous HAMA interference occurring in healthy donors.",
"Language": "en",
"Country": "XG",
"Code": "Applications"
},
{
"Name": "CB - Order Information",
"Value": "Will be supplied as \"Hama-Serum I - Qual. Standard *SQ\". Unit of measure is \"piece\".",
"Language": "en",
"Country": "XG",
"Code": "CB - Order Information"
},
{
"Name": "Product Description",
"Value": "HAMA Serum Type I is a lyophilized human serum with serum ingredients within normal range. No preservative are added. The product must be handled just as carefully as patient specimens.",
"Language": "en",
"Country": "XG",
"Code": "Product Description"
},
{
"Name": "Background Information",
"Value": "HAMA serum interferences in immunoassays can vary within a broad range depending on the person's immune system.",
"Language": "en",
"Country": "XG",
"Code": "Background Information"
},
{
"Name": "Properties",
"Value": "
pH value (+25°C): 7-8
Protein (Biuret): ≥65 mg/vial
Dilution: Up to 1:20 recommended
Solubility: Reconstitution of lyophilizate/vial in 1 mL water results in serum typical solution
Typical concentrations determined by Roche cobas® assays:
Alpha fetoprotein (AFP): 2.0 IU/mL
Carcinoembryonic antigen (CEA): 1.3 ng/mL
Follicle stimulating hormone (FSH): 10.0 mIU/mL
Human chorionic gonadotropin (HCG): 2.8 mIU/mL
Luteinizing hormone (LH): 8.1 mIU/mL
Prolactin: 160.7 μIU/mL
Prostate specific antigen (PSA): 0.3 ng/mL
PSA free: 0.06 ng/mL
Thyroid stimulating homone (TSH): 2.5 μIU/mL
Troponin T (TN-T): Not detectable",
"Language": "en",
"Country": "XG",
"Code": "Properties"
},
{
"Name": "Specification",
"Value": "
Appearance: Yellowish lyophilizate
Interference effect: Corresponds to specification
Infectious parameters (determined by FDA approved methods):
Non reactive HbsAg: Corresponds to specification
Anti HIV 1+2: Negative
Anti HCV: Negative
HIV 1 NAT, non reactive: Corresponds to specification
Stability: At -15 to - 25°C within specification range for 24 months.",
"Language": "en",
"Country": "XG",
"Code": "Specification"
}
]
}
}
]
}